All Stories

  1. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple‐Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  2. Proteomics Landscape of Triple-Negative Apocrine Breast Carcinoma Reveals Molecular Mechanisms of Tumorigenesis and Characteristics of Chemo-insensitivity
  3. Bridging Discoveries and Treatments: The New Landscape of Breast Cancer Research
  4. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  5. MSGM: An Advanced Deep Multi-Size Guiding Matching Network for Whole Slide Histopathology Images Addressing Staining Variation and Low Visibility Challenges
  6. Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
  7. An orientation-free ring feature descriptor with stain-variability normalization for pathology image matching
  8. Author Correction: The landscape of viral associations in human cancers
  9. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes
  10. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  11. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  12. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  13. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  14. Author Correction: Pan-cancer analysis of whole genomes
  15. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  16. Author Correction: Genomic basis for RNA alterations in cancer
  17. Author Correction: Patterns of somatic structural variation in human cancer genomes
  18. Author Correction: The evolutionary history of 2,658 cancers
  19. Author Correction: The repertoire of mutational signatures in human cancer
  20. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  21. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  22. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  23. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  24. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  25. Author Correction: Inferring structural variant cancer cell fraction
  26. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  27. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  28. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  29. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  30. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  31. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  32. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  33. Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard
  34. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  35. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  36. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  37. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  38. HER2-low-positive features a distinct subtype in estrogen receptor-positive breast cancer associated with endocrine therapy resistance
  39. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  40. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  41. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  42. Intraparenchymal breast leiomyoma and atypical leiomyoma
  43. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  44. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  45. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  46. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  47. Triple negative apocrine breast carcinoma has better prognosis despite poor response to neoadjuvant chemotherapy
  48. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  49. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  50. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  51. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  52. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  53. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  54. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  55. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  56. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  57. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  58. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  59. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  60. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  61. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  62. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  63. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  64. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  65. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  66. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  67. Sex differences in oncogenic mutational processes
  68. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  69. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  70. Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  71. Detecting viruses in tumour tissue to discover links between cancer and infection
  72. Inferring structural variant cancer cell fraction
  73. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  74. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  75. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  76. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  77. Combined burden and functional impact tests for cancer driver discovery using DriverPower
  78. Divergent mutational processes distinguish hypoxic and normoxic tumours
  79. Genomic footprints of activated telomere maintenance mechanisms in cancer
  80. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  81. Integrative pathway enrichment analysis of multivariate omics data
  82. Pathway and network analysis of more than 2500 whole cancer genomes
  83. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  84. Comprehensive molecular characterization of mitochondrial genomes in human cancers
  85. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  86. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  87. Butler enables rapid cloud-based analysis of thousands of human genomes
  88. Genomic basis for RNA alterations in cancer
  89. Patterns of somatic structural variation in human cancer genomes
  90. The repertoire of mutational signatures in human cancer
  91. Pan-cancer analysis of whole genomes
  92. The evolutionary history of 2,658 cancers
  93. Genomic subtyping of liver cancers with prognostic application
  94. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  95. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  96. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  97. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  98. Forward and reverse mutations in stages of cancer development
  99. Forward-reverse mutation cycles between stages of cancer development
  100. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  101. Tripartite genome of all species
  102. Feature co-localization landscape of the human genome
  103. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  104. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  105. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later